Related Experiment Video
Updated: Jun 4, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Adverse drug reactions linked to Ciwujia injection: a systematic review of 521 cases
Jing Hu1, Hongcai Shang, Jing Li
1Evidence-based Medicine Centre, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
Objective:
To analyze adverse drug reactions (ADRs) associated with Ciwujia injection and possible contributing factors.
Methods:
We searched all clinical studies and ADR reports of Ciwujia injection from the China National Knowledge Infrastructure (CNKI) database. Relevant information such as disease treated; menstruum and compatibility of the Ciwujia injection; age, gender, and allergic history of ADR cases; and the types, occurrence time and severity of the ADRs were collected and analyzed.
Results:
In the 800 clinical studies of Ciwujia injection's efficacy and safety, 97 (12.1%) reported 285 ADR cases. There were 144 ADR reports for the drug describing a total of 236 ADR cases. Most of the ADR reports described cases of anaphylactic shock, while the most common ADR reported in clinical studies was local pain; 27.7% of ADR cases were I to II class in all 521 cases, and four anaphylactic shock cases died.
Conclusion:
The relevant information of ADRs for Ciwujia injection was insufficiently reported in included studies. The ADR type distribution between clinical studies and ADR reports was inconsistency. Most of the reported ADRs were mild, and were treated successfully by slowing down the drip velocity or by withdrawing the drug and treating the symptoms. As Ciwujia injection was one of the highest numbers of ADR reports of traditional Chinese medicine injections, high quality ADR monitoring, standardized ADR reporting, and timely analysis risk factors of ADRs are extremely urgent.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
Allergic Drug Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Hypersensitivity Reactions: Immune-Complex Reactions